Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Ratziu V, Karlsen TH(2024) Introducing the Updates in Clinical Science: A focus on recent data of high impact J Hepatol(in press) DOI 10.1016/j.jhep.2024.12.007, PubMed 39718488
Watland S, Solberg Nes L, Ekeberg Ø, Rostrup M, Hanson E, Ekstedt M, Stenberg U, Hagen M, Børøsund E(2024) The Caregiver Pathway Intervention Can Contribute to Reduced Post-Intensive Care Syndrome Among Family Caregivers of ICU Survivors: A Randomized Controlled Trial Crit Care Med(in press) DOI 10.1097/CCM.0000000000006546, PubMed 39718436
Wynne R, Jedwab RM, Gjeilo KH, Fredericks S, Magboo R, Phillips EK, Goudarzi Rad M, O'Keefe-Mccarthy S, Keeping-Burke L, Murfin J, Killackey T, Bruneau J, Matthews S, Bowden T, Sanders J, Lie I, CONNECT: the Cardiac Surgery International Nursing & Allied Professional Research Network(2024) A Systematic Review of Multimodal Analgesic Effectiveness on Acute Postoperative Pain After Adult Cardiac Surgery J Adv Nurs(in press) DOI 10.1111/jan.16688, PubMed 39704393